Results 321 to 330 of about 93,898 (384)

Severe Eosinophilic Asthma and Severe Mixed Polyneuropathy: A Case of Eosinophilic Granulomatous Vasculitis With Polyangiitis and New Therapeutic Perspectives

María del Carmen Lorenzo Martínez, Ángela Hidalgo Herranz, Ana María Ochoa Ruiz, Bárbara Gutierrez Ruano, Raúl Ruiz Esteban, Sergio Campos Téllez, José Javier Jareño Esteban   +6 more
openalex   +1 more source

Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)"

Cabrera-Perez, Javier S, Eigenmann, Philippe, Akenroye, Ayobami   +2 more
openalex   +1 more source

Best of United European Gastroenterology Week 2025

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Iuliana Nenu, Sara Nikolic, Eduardo Valdivielso, Giovanni Marasco   +3 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mepolizumab for severe eosinophilic asthma

Expert Review of Respiratory Medicine
M. Kallieri, A. Papaioannou, S. Loukides
semanticscholar   +2 more sources

Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma

International Archives of Allergy and Immunology, 2023
Introduction: Mucus plugs are associated with airway obstruction in severe asthma and are involved in the formation of activated eosinophils. Benralizumab, an anti-interleukin-5 receptor antibody, markedly reduces not only peripheral blood eosinophils ...
Natsumi Sakai, T. Koya, Yuihci Murai, F. Tsubokawa, Kentaro Tanaka, S. Naramoto, A. Aoki, K. Shima, Y. Kimura, Satoshi Watanabe, T. Hasegawa, T. Kikuchi   +11 more
semanticscholar   +1 more source

Clusters of Severe Eosinophilic Asthma in a Korean Asthma Cohort

Respiration, 2021
<b><i>Background:</i></b> Targeted therapies have broadened the available treatment options for patients with severe eosinophilic asthma (SEA). However, differences in the magnitude of treatment responses among patients indicate the presence of various underlying pathophysiological processes and patient subgroups. <b><i&
Ji-Hyang Lee, Jin An, Ha-Kyeong Won, Bomi Seo, Jung-Hyun Kim, So-Young Park, Min-Hye Kim, Yoo Seob Shin, Jae-Woo Jung, Woo-Jung Song, Taehoon Lee, Hyouk-Soo Kwon, Jae Hyun Lee, Joo-Hee Kim, Sae-Hoon Kim, Yoon-Seok Chang, You Sook Cho, Dong-Ho Nahm, An-Soo Jang, Jung-Won Park, Ho-Joo Yoon, Sang-Heon Cho, Young-Joo Cho, Byoung Whui Choi, Hee-Bom Moon, Tae-Bum Kim   +25 more
openaire   +2 more sources

Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real-life study

Acta bio-medica : Atenei Parmensis, 2023
Background and aim: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a frequent comorbidity in severe eosinophilic asthma (SEA), which may contribute to the loss of asthma control. CRSwNP and SEA share a T2-mediated mechanism and the use of some anti-
C. Santomasi, E. Buonamico, S. Dragonieri, L. Iannuzzi, Andrea Portacci, N. Quaranta, G. E. Carpagnano   +6 more
semanticscholar   +1 more source